Wells Fargo Reiterates Overweight Rating on Nurix (NRIX)

Go back to Wells Fargo Reiterates Overweight Rating on Nurix (NRIX)

Form 10-Q Nurix Therapeutics, Inc. For: Aug 31

October 11, 2024 4:06 PM EDT

... More

Form 8-K Nurix Therapeutics, Inc. For: Oct 11

October 11, 2024 4:02 PM EDT

... More